Insider · CIK 0001404955

Harrison Seth Loring

Reports to the SEC for 6 companies · BEDFORD, MA

sec.gov

Transactions

Companies

Filings

CIK

0001404955

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	−19.4K sh	—	—	0
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	−21K sh	—	—	0
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	−14.8K sh	—	—	0
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	−17.8K sh	—	—	0
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	−29.7K sh	—	—	0
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	+21K sh	—	—	21,000
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	+29.6K sh	—	—	29,555
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	+7,639 sh	—	—	7,639
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	−29.6K sh	—	—	0
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	+11.7K sh	—	—	11,650
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	+17.8K sh	—	—	17,786
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	+19.4K sh	—	—	19,441
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	−7,639 sh	—	—	0
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	+29.7K sh	—	—	29,747
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	−11.7K sh	—	—	0
2026-07-16	STOKStoke Therapeutics, Inc. · Stock Option (Right to Buy)G Gift	Director	GGift	+14.8K sh	—	—	14,777
2026-06-03	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+17.8K sh	—	—	17,786
2025-12-09	Akero Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−9,398 sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−136K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−148K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-06-03	Akero Therapeutics, Inc.A Award	Director	AAward	+9,398 sh	—	—	145,699
2025-06-03	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+29.7K sh	—	—	29,747
2024-06-08	Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2024-06-05	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+7,639 sh	—	—	7,639
2023-06-23	Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-06-13	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+19.4K sh	—	—	19,441
2022-11-30	Akero Therapeutics, Inc.S Sale	Director	SSale	−5,179 sh	$47.60	−$247K	148,063
2022-11-30	Akero Therapeutics, Inc.S Sale	Director	SSale	−6,851 sh	$46.44	−$318K	153,242
2022-11-30	Akero Therapeutics, Inc.S Sale	Director	SSale	−4,779 sh	$47.60	−$228K	136,301
2022-11-30	Akero Therapeutics, Inc.S Sale	Director	SSale	−6,322 sh	$46.44	−$294K	141,080
2022-10-28	Akero Therapeutics, Inc.S Sale	Director	SSale	−22.1K sh	$40.28	−$890K	160,962
2022-10-28	Akero Therapeutics, Inc.S Sale	Director	SSale	−800 sh	$41.12	−$32.9K	147,402
2022-10-28	Akero Therapeutics, Inc.S Sale	Director	SSale	−20.3K sh	$40.28	−$819K	148,202
2022-10-28	Akero Therapeutics, Inc.S Sale	Director	SSale	−869 sh	$41.12	−$35.7K	160,093
2022-10-27	Akero Therapeutics, Inc.S Sale	Director	SSale	−4,013 sh	$43.23	−$173K	183,058
2022-10-27	Akero Therapeutics, Inc.S Sale	Director	SSale	−23.7K sh	$42.03	−$997K	187,071
2022-10-27	Akero Therapeutics, Inc.S Sale	Director	SSale	−44.4K sh	$41.12	−$1.83M	210,790
2022-10-27	Akero Therapeutics, Inc.S Sale	Director	SSale	−3,693 sh	$43.23	−$160K	168,540
2022-10-27	Akero Therapeutics, Inc.S Sale	Director	SSale	−21.8K sh	$42.03	−$918K	172,233
2022-10-27	Akero Therapeutics, Inc.S Sale	Director	SSale	−40.9K sh	$41.12	−$1.68M	194,063
2022-10-26	Akero Therapeutics, Inc.S Sale	Director	SSale	−20.1K sh	$44.90	−$902K	255,230
2022-10-26	Akero Therapeutics, Inc.S Sale	Director	SSale	−12.5K sh	$43.97	−$551K	275,315
2022-10-26	Akero Therapeutics, Inc.S Sale	Director	SSale	−39K sh	$43.08	−$1.68M	287,852
2022-10-26	Akero Therapeutics, Inc.S Sale	Director	SSale	−18.5K sh	$44.90	−$830K	234,966

Recent filings

Accepted (ET)
Jul 174
Harrison Seth Loring0001404955-26-000006
SEC(opens sec.gov)
Jun 54
Harrison Seth Loring0001404955-26-000002
SEC(opens sec.gov)
Dec 94
Harrison Seth Loring0001193125-25-312127
SEC(opens sec.gov)

Companies

Address

C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE

BEDFORD, MA, 01730